{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:35:30Z","timestamp":1791920130706,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.cbi.2024.110902","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T11:12:56Z","timestamp":1707995576000},"page":"110902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Assessment of anti-hyperglycemic and anti-hyperlipidemic effects of thiazolidine-2,4-dione derivatives in HFD-STZ diabetic animal model"],"prefix":"10.1016","volume":"391","author":[{"given":"Saad","family":"Fettach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Zahra","family":"Thari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Karrouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Benbacer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Learn-Han","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelhakim","family":"Bouyahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahia","family":"Cherrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Sefrioui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Bougrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My El Abbes","family":"Faouzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2024.110902_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.sajb.2019.08.010","article-title":"Phenolic content, acute toxicity of Ajuga iva extracts and assessment of their antioxidant and carbohydrate digestive enzyme inhibitory effects","volume":"125","author":"Fettach","year":"2019","journal-title":"South Afr. J. Bot."},{"key":"10.1016\/j.cbi.2024.110902_bib2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.biopha.2018.07.157","article-title":"Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: an update on glucose toxicity","volume":"107","author":"Giri","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2024.110902_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fendo.2017.00006","article-title":"Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management","volume":"8","author":"Chaudhury","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cbi.2024.110902_bib4","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.1080\/07391102.2021.1911854","article-title":"Synthesis, \u03b1-glucosidase and \u03b1-amylase inhibitory activities, acute toxicity and molecular docking studies of thiazolidine-2, 4-diones derivatives","volume":"40","author":"Fettach","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.cbi.2024.110902_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13340-019-00409-6","article-title":"Drug development research for novel adiponectin receptor-targeted antidiabetic drugs contributing to healthy longevity","volume":"10","author":"Okada-Iwabu","year":"2019","journal-title":"Diabetology International"},{"key":"10.1016\/j.cbi.2024.110902_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17082-x","article-title":"Structures of PPAR\u03b3 complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2024.110902_bib7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.bioorg.2018.02.009","article-title":"Thiazolidinediones as antidiabetic agents: a critical review","volume":"77","author":"Nanjan","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.cbi.2024.110902_bib8","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1159\/000492091","article-title":"High fat diet upregulates fatty acid oxidation and ketogenesis via intervention of PPAR-\u03b3","volume":"48","author":"Sikder","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cbi.2024.110902_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-018-0933-z","article-title":"Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-\u03b3 and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet","volume":"18","author":"Zheng","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.cbi.2024.110902_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.molstruc.2016.12.006","article-title":"3D-QSAR and virtual screening studies of thiazolidine-2,4-dione analogs: validation of experimental inhibitory potencies towards PIM-1 kinase","volume":"1133","author":"Asati","year":"2017","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.cbi.2024.110902_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jics.2023.101100","article-title":"Design, synthesis and anti-hyperglycemic assessments of novel 5-benzylidenethiazolidine-2,4-dione derivatives as PPAR-\u03b3 agonist","volume":"100","author":"Ali","year":"2023","journal-title":"J. Indian Chem. Soc."},{"key":"10.1016\/j.cbi.2024.110902_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135596","article-title":"Identification of potential N-substituted 5-benzylidenethiazolidine-2,4-dione derivatives as \u03b1-amylase inhibitors: computational cum synthetic studies","volume":"1287","author":"Gupta","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.cbi.2024.110902_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115826","article-title":"Integrated fragment-based drug design and virtual screening techniques for exploring the antidiabetic potential of thiazolidine-2,4-diones: design, synthesis and in vivo studies","volume":"261","author":"Gupta","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110902_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5530\/ijper.51.3.72","article-title":"SWFB and GA strategies for variable selection in QSAR studies for the validation of thiazolidine- 2,4-dione derivatives as promising antitumor candidates","volume":"51","author":"Asati","year":"2017","journal-title":"IJPER"},{"key":"10.1016\/j.cbi.2024.110902_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/slct.201702392","article-title":"Virtual screening, molecular docking, and DFT studies of some thiazolidine-2,4-diones as potential PIM-1 kinase inhibitors","volume":"3","author":"Asati","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.cbi.2024.110902_bib16","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ejmech.2016.12.020","article-title":"Thiazolidinediones and PPAR orchestra as antidiabetic agents: from past to present","volume":"126","author":"Yasmin","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110902_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.intimp.2018.02.011","article-title":"New thiazolidinedione LPSF\/GQ-2 inhibits NF\u03baB and MAPK activation in LPS-induced acute lung inflammation","volume":"57","author":"dos Santos","year":"2018","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.cbi.2024.110902_bib18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s13105-020-00760-2","article-title":"Role of miRNAs in the pathogenesis of T2DM, insulin secretion, insulin resistance, and \u03b2 cell dysfunction: the story so far","volume":"76","author":"Kaur","year":"2020","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.cbi.2024.110902_bib19","first-page":"46","volume":"16","author":"Khillare","year":"2017"},{"key":"10.1016\/j.cbi.2024.110902_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13065-017-0357-2","article-title":"Biological potential of thiazolidinedione derivatives of synthetic origin","volume":"11","author":"Sucheta","year":"2017","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.cbi.2024.110902_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3390\/pharmaceutics13030315","article-title":"Mechanistic insights into side effects of troglitazone and rosiglitazone using a novel inverse molecular docking protocol","volume":"13","author":"Kores","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cbi.2024.110902_bib22","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.3390\/molecules25184271","article-title":"Synthesis, antimicrobial and antioxidant activities of 2-isoxazoline derivatives","volume":"25","author":"Alshamari","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2024.110902_bib23","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1039\/C9MD00276F","article-title":"Evaluation of anti-inflammatory activity and molecular docking study of new aza-bicyclic isoxazoline acylhydrazone derivatives","volume":"10","author":"Mota","year":"2019","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.cbi.2024.110902_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1021\/acs.orglett.6b03380","article-title":"Green organocatalytic synthesis of isoxazolines via a one-pot oxidation of allyloximes","volume":"19","author":"Triandafillidi","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.cbi.2024.110902_bib25","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1016\/j.bmcl.2018.10.046","article-title":"Synthesis of new coumarin tethered isoxazolines as potential anticancer agents","volume":"28","author":"Lingaraju","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2024.110902_bib26","doi-asserted-by":"crossref","first-page":"30223","DOI":"10.1039\/D0RA06148D","article-title":"Synthesis and biological evaluation of fluoro-substituted spiro-isoxazolines as potential anti-viral and anti-cancer agents","volume":"10","author":"Das","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.cbi.2024.110902_bib27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejmech.2013.10.005","article-title":"Synthesis, biological evaluation and molecular modeling studies of some novel thiazolidinediones with triazole ring","volume":"70","author":"Chinthala","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110902_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ultsonch.2020.105222","article-title":"Ultrasound-assisted one-pot green synthesis of new N- substituted-5-arylidene-thiazolidine-2,4-dione-isoxazoline derivatives using NaCl\/Oxone\/Na3PO4 in aqueous media","volume":"68","author":"Thari","year":"2020","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.cbi.2024.110902_bib29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jdi.12235","article-title":"Modeling type 2 diabetes in rats using high fat diet and streptozotocin","volume":"5","author":"Skovs\u00f8","year":"2014","journal-title":"Journal of Diabetes Investigation"},{"key":"10.1016\/j.cbi.2024.110902_bib30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jff.2017.12.031","article-title":"Prepared Rehmanniae Radix oligosaccharide regulates postprandial and diabetic blood glucose in mice","volume":"41","author":"Chiu","year":"2018","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.cbi.2024.110902_bib31","series-title":"Arbutus Unedo L Aqueous Extract Is Associated with in Vitro and in Vivo Antioxidant Activity","author":"Mrabti","year":"2017"},{"key":"10.1016\/j.cbi.2024.110902_bib32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2527\/jam2016-0724","article-title":"0724 Use of 1,25(OH)2 vitamin D3 to maintain postpartum blood calcium and improve immune function in dairy cows","volume":"94","author":"Neto","year":"2016","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.cbi.2024.110902_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200452","article-title":"A comprehensive review on the antidiabetic attributes of thiazolidine-4-ones: synthetic strategies and structure\u2013activity relationships","volume":"356","author":"Pradhan","year":"2023","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.cbi.2024.110902_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115826","article-title":"Integrated fragment-based drug design and virtual screening techniques for exploring the antidiabetic potential of thiazolidine-2,4-diones: design, synthesis and in vivo studies","volume":"261","author":"Gupta","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110902_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115957","article-title":"Synthesis and biological evaluation of indole derivatives containing thiazolidine-2,4-dione as \u03b1-glucosidase inhibitors with antidiabetic activity","volume":"264","author":"Hu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110902_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134625","article-title":"Synthesis, characterization, crystallographic, binding, in silico and antidiabetic studies of novel 2,4-thiazolidinedione-phenothiazine molecular hybrids","volume":"1276","author":"Doddagaddavalli","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.cbi.2024.110902_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115591","article-title":"SAR and lead optimization of (Z)-5-(4-hydroxy-3-methoxybenzylidene)-3-(2-morpholinoacetyl)thiazolidine-2,4-dione as a potential multi-target antidiabetic agent","volume":"258","author":"Shah","year":"2023","journal-title":"Eur. J. Med. Chem."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724000486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724000486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:50:53Z","timestamp":1762113053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724000486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":37,"alternative-id":["S0009279724000486"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.110902","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of anti-hyperglycemic and anti-hyperlipidemic effects of thiazolidine-2,4-dione derivatives in HFD-STZ diabetic animal model","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.110902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110902"}}